Along with our results that co-expression of CYB561 and PAM is only detected in PC-3 cells, these findings provide evidentiary support that the neuropeptide activation function of CYB561 may be more relevant in NEPC compared to androgen-dependent metastatic PCa. The gene discussed is CYB561; the disease is posterior cortical atrophy.